Skip to main content
OpenTrials

Clinical trial condition

Immune Checkpoint Inhibition

Explore clinical trials studying Immune Checkpoint Inhibition. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Immune Checkpoint Inhibition trial results

Active, Not Recruiting

REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer

NCT03610711

Conditions
GastroEsophageal Cancer, Immune Checkpoint Inhibition
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Alleghany Health Network Pittsburgh, Pennsylvania, United States
  • Baylor University Dallas, Texas, United States
View Trial Details

Related conditions